therapy resulted in symptomatic relief with hematologic and virologic improvement.
The VL is associated with bone marrow, spleen, liver and lymph node involvement. Infection of the digestive tract may occur, in the setting of profound immunosuppression. Leishmania species can invade any part of the digestive tract, with the duodenum being most commonly affected. Their presence is frequently accompanied by other pathogens, such as cytomegalovirus or Candida species [1] .
Esophageal infection in HIV patients usually indicates the onset of the symptomatic stage. The majority of cases are due to Candida species, but herpes simplex virus and cytomegalovirus may participate. Patients who are not taking antiretroviral therapy or have not attained immune reconstitution despite treatment and those with extremely low CD4 lymphocyte count are at high risk [1] .
The current standard of care is to treat an AIDS patient complaining of dysphagia and/or odynophagia with systemic antifungal agents on the basis of compatible oropharyngeal lesions. If symptoms do not improve within the first few days, endoscopy and biopsy should be performed, since it is likely that a disease other than or in addition to Candida esophagitis is present, as in our patient.
To date, there have been only a few published reports of esophageal leishmaniasis in HIV patients [2] [3] [4] [5] . Our case emphasizes the importance of endoscopy, pathology and histochemistry in identifying uncommon causes of persisting dysphagia in immunocompromised individuals. 
